{
  "exposures": [
    {
      "id": "1",
      "trait": "Sodium-glucose cotransporter 2 (SGLT2) inhibition",
      "category": "Other"
    }
  ],
  "outcomes": [
    {
      "id": "1",
      "trait": "Heart Failure (HF)",
      "category": "disease of the circulatory system"
    },
    {
      "id": "2",
      "trait": "4,907 circulating proteins",
      "category": "molecular"
    }
  ],
  "methods": [
    "two-sample, two-step Mendelian Randomization (MR) analysis"
  ],
  "population": [
    "genetic variants linked to SGLT2 inhibition derived from previous studies",
    "4,907 circulating proteins derived from the deCODE study",
    "genetic links to HF obtained through the Heart Failure Molecular Epidemiology for Therapeutic Targets (HERMES) consortium"
  ],
  "metainformation": {
    "error": "Some exposures and outcomes do not fit into the provided categories",
    "explanation": "SGLT2 inhibition is not categorized as it is a treatment, not a disease or condition. The 4907 circulating proteins are also not categorized as they are a group of molecules, not a disease or condition."
  }
}
